Over-expression of microRNA-25 promotes cell proliferation and induces cell apoptosis in patients with hepatocellular carcinoma

被引:0
作者
Liu, Bo [1 ]
Yang, Jihong [1 ]
Wang, Gang [2 ]
Zhang, Quan [1 ]
Li, Jinghua [1 ]
机构
[1] Affiliated Hosp Hebei Univ, Dept Hepatobiliary Surg, Baoding 071000, Hebei Province, Peoples R China
[2] Three Gorges Univ Peoples Hosp, Peoples Hosp Yichang 1, Dept Gen Surg, Yichang, Hubei Province, Peoples R China
关键词
Hepatocellular carcinoma; miR-25; proliferation; apoptosis; prognosis; NONCODING RNAS; MIR-25; GROWTH; CANCER; IDENTIFICATION; CLUSTER;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Backgrounds: microRNAs (miRNAs) have been confirmed to play an important role in the occurrence and development of cancers. The purpose of this study was to investigate the effects of miR-25 on the cell growth of HCC and its prognostic role. Methods: The expression of miR-25 was detected by quantitative real-time reverse transcriptase-polymerase chain reaction (qRT-PCR) analysis. The relationship between miR-25 expression and clinical factors was also analyzed. The proliferation and apoptosis assay were conducted to compare the influences of miR-25 expression on cell growth. Kaplan-Meier analysis was used to evaluate the overall survival of patients with different miR-25 expression. The prognostic value was estimated via Cox regression analysis. Results: miR-25 was over-expression in HCC tissues compared to adjacent normal tissues. And its expression was influenced by AFP significantly. The cell proliferation of HCC cells was promoted by miR-25 while the apoptosis of it was inhibited. Patients with high miR-25 expression had a shorter overall survival than those with low expression through Kaplan-Meier analysis. Cox regression analysis showed high expression of miR-25 was closely related to the prognosis of HCC. Conclusions: miR-25 was increased in HCC patients and it could promote cell proliferation as well as suppress cell apoptosis. Moreover, it might serve as an independent marker in the prognosis of HCC.
引用
收藏
页码:3396 / 3402
页数:7
相关论文
共 32 条
[1]  
[Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
[2]  
[Anonymous], TUMOUR BIOL
[3]   Cellular and molecular mechanisms of hepatocellular carcinoma: an update [J].
Aravalli, Rajagopal N. ;
Cressman, Erik N. K. ;
Steer, Clifford J. .
ARCHIVES OF TOXICOLOGY, 2013, 87 (02) :227-247
[4]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[5]   Survey of MicroRNA Expression in Pediatric Brain Tumors [J].
Birks, Diane K. ;
Barton, Valerie N. ;
Donson, Andrew M. ;
Handler, Michael H. ;
Vibhakar, Rajeev ;
Foreman, Nicholas K. .
PEDIATRIC BLOOD & CANCER, 2011, 56 (02) :211-216
[6]  
Buonaguro L, 2015, CANC IMMUNOL IMMUNOT
[7]   A protective effect after clearance of orthotopic rat hepatocellular carcinoma by nanosecond pulsed electric fields [J].
Chen, Ru ;
Sain, Nova M. ;
Harlow, K. Tyler ;
Chen, Yeong-Jer ;
Shires, Peter K. ;
Heller, Richard ;
Beebe, Stephen J. .
EUROPEAN JOURNAL OF CANCER, 2014, 50 (15) :2705-2713
[8]   miRNA expression profiling of lung adenocarcinomas: correlation with mutational status [J].
Dacic, Sanja ;
Kelly, Lindsey ;
Shuai, Yongli ;
Nikiforova, Marina N. .
MODERN PATHOLOGY, 2010, 23 (12) :1577-1582
[9]   Diagnosis and treatment of hepatocellular carcinoma [J].
El-Serag, Hashem B. ;
Marrero, Jorge A. ;
Rudolph, Lenhard ;
Reddy, K. Rajender .
GASTROENTEROLOGY, 2008, 134 (06) :1752-1763
[10]   CURRENT CONCEPTS Hepatocellular Carcinoma [J].
El-Serag, Hashem B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (12) :1118-1127